Heparan sulfate deficiency leads to hypertrophic chondrocytes by increasing bone morphogenetic protein signaling

Osteoarthritis Cartilage. 2020 Nov;28(11):1459-1470. doi: 10.1016/j.joca.2020.08.003. Epub 2020 Aug 18.

Abstract

Objective: Exostosin-1 (EXT1) and EXT2 are the major genetic etiologies of multiple hereditary exostoses and are essential for heparan sulfate (HS) biosynthesis. Previous studies investigating HS in several mouse models of multiple hereditary exostoses have reported that aberrant bone morphogenetic protein (BMP) signaling promotes osteochondroma formation in Ext1-deficient mice. This study examined the mechanism underlying the effects of HS deficiency on BMP/Smad signaling in articular cartilage in a cartilage-specific Ext-/- mouse model.

Method: We generated mice with a conditional Ext1 knockout in cartilage tissue (Ext1-cKO mice) using Prg4-Cre transgenic mice. Structural cartilage alterations were histologically evaluated and phospho-Smad1/5/9 (pSmad1/5/9) expression in mouse chondrocytes was analyzed. The effect of pharmacological intervention of BMP signaling using a specific inhibitor was assessed in the articular cartilage of Ext1-cKO mice.

Results: Hypertrophic chondrocytes were significantly more abundant (P = 0.021) and cartilage thickness was greater in Ext1-cKO mice at 3 months postnatal than in control littermates (P = 0.036 for femur; and P < 0.001 for tibia). However, osteoarthritis did not spontaneously occur before the 1-year follow-up. matrix metalloproteinase (MMP)-13 and adamalysin-like metalloproteinases with thrombospondin motifs(ADAMTS)-5 were upregulated in hypertrophic chondrocytes of transgenic mice. Immunostaining and western blotting revealed that pSmad1/5/9-positive chondrocytes were more abundant in the articular cartilage of Ext1-cKO mice than in control littermates. Furthermore, the BMP inhibitor significantly decreased the number of hypertrophic chondrocytes in Ext1-cKO mice (P = 0.007).

Conclusions: HS deficiency in articular chondrocytes causes chondrocyte hypertrophy, wherein upregulated BMP/Smad signaling partially contributes to this phenotype. HS might play an important role in maintaining the cartilaginous matrix by regulating BMP signaling.

Keywords: Bone morphogenetic protein signaling; Chondrocyte; Ext1; Heparan sulfate; Hypertrophy; Prg4.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADAMTS5 Protein / metabolism
  • Animals
  • Bone Morphogenetic Proteins / antagonists & inhibitors
  • Bone Morphogenetic Proteins / metabolism*
  • Cartilage, Articular / cytology
  • Cartilage, Articular / metabolism*
  • Chondrocytes / metabolism*
  • Chondrocytes / pathology
  • Disease Models, Animal
  • Heparitin Sulfate / deficiency*
  • Hypertrophy
  • Matrix Metalloproteinase 13 / metabolism
  • Mice
  • Mice, Knockout
  • Mice, Transgenic
  • N-Acetylglucosaminyltransferases / genetics
  • Osteoarthritis, Knee / genetics
  • Osteoarthritis, Knee / metabolism*
  • Osteoarthritis, Knee / pathology
  • Pyrazoles / pharmacology
  • Pyrimidines / pharmacology
  • Smad1 Protein / metabolism
  • Smad5 Protein / metabolism
  • Smad8 Protein / metabolism

Substances

  • Bone Morphogenetic Proteins
  • LDN 193189
  • Pyrazoles
  • Pyrimidines
  • Smad1 Protein
  • Smad1 protein, mouse
  • Smad5 Protein
  • Smad5 protein, mouse
  • Smad8 Protein
  • Smad9 protein, mouse
  • Heparitin Sulfate
  • N-Acetylglucosaminyltransferases
  • exostosin-1
  • ADAMTS5 Protein
  • Adamts5 protein, mouse
  • Matrix Metalloproteinase 13
  • Mmp13 protein, mouse